The Director Of 1Life Healthcare Inc. (ONEM) Purchased 2,778 Shares Leave a comment

As of Friday close, 1Life Healthcare Inc.’s (NASDAQ:ONEM) stock was up $0.72, moving up 6.50 percent to $11.80. The average number of shares traded per day over the past five days has been 1,734,820 shares. 4 times new highs have been achieved over the past 5 days, with a $1.64 gain in that time frame. In the last twenty days, the average volume was 2,440,030, while in the previous 50 days, it was 2,621,538.

Since last month, ONEM stock rose 11.85%. Shares of the company fell to $7.02 on 03/14/22, the lowest level in the past month. A 52-week high of $45.63 was reached on 01/04/22 after having rallying from a 52-week low of $7.02. Since the beginning of this year, ONEM’s stock price has dropped by -32.84% or -$5.77, and marked a new high 2 times. However, the stock has declined by -74.14% since its 52-week high.

1Life Healthcare Inc. (ONEM) last reported insider trading activity 194 days ago on Sep 20. Kennedy David P, the Director of the company, disposed of 2,778 shares for $24.72 on Sep 20. It resulted in a $68,673 divestment by the insider. Kennedy David P sold 2,778 shares at an average price of $23.40 on Aug 18. The insider now owns 253,557 shares following the transaction. On Jul 19, Director Kennedy David P sold 2,778 shares at $26.49 apiece. The transaction was valued at $73,580.

Financial Health

In the three months ended December 30, 1Life Healthcare Inc.’s quick ratio stood at 3.00, while its current ratio was 3.00, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending December 30 was 0.18. On the profitability front, the trailing twelve-month gross margin is 30.00% percent. In the year ended December 30, operating margins totaled -39.20%. Based on annual data, ONEM earned $188.13 million in gross profit and brought in $623.32 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -11.90%. Return on equity (ROE) for the past 12 months was -22.80%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. ONEM’s revenue rose 47.09% to $151.33 million during the quarter, while net income inched up to $230.21 million. While analysts expected 1Life Healthcare Inc. to report -$0.52 quarterly earnings, the actual figure was -$0.5 per share, beating the consensus estimate by 3.80%. During the quarter, the company generated -$67.08 million in EBITDA. The liabilities of 1Life Healthcare Inc. were 898.45 million at the end of its most recent quarter ended December 30, and its total debt was $610.64 million. The value of shareholders’ equity is $192.09 million.

Technical Picture

This quick technical analysis looks at 1Life Healthcare Inc.’s (ONEM) price momentum. With a historical volatility rate of 54.03%, the RSI 9-day stood at 66.85% on 01 April.

With respect to its five-day moving average, the current 1Life Healthcare Inc. price is up by +16.14% percent or $1.64. At present, ONEM shares trade +16.37% above its 20-day simple moving average and -47.99% percent below its 100-day simple moving average. However, the stock is currently trading approximately +5.08% above its SMA50 and -65.08% below its SMA200.

Stochastic coefficient K was 92.95% and Stochastic coefficient D was 92.68%, while ATR was 0.82. Given the Stochastic reading of 98.08% for the 14-day period, the RSI (14) reading has been calculated as 60.04%. As of today, the MACD Oscillator reading stands at 0.52, while the 14-day reading stands at 0.94.

With a median target price of $15.00, the current consensus forecast for the stock is $10.00 – $25.00. Based on these forecasts, analysts predict 1Life Healthcare Inc. (ONEM) will achieve an average price target of $15.31.


Leave a Reply